Argentina
October 20, 2021
_0.png)
In 2022, Rizobacter plans to open an adjuvants plant in Londrina to supply the growing crop protection market.
Rizobacter, one of the leading global biological companies, announced the construction of the new plant in Brazil, adding significant depth to its international expansion. Currently, the company has eight subsidiaries in Latin America, the United States, Europe, and South Africa, and a commercial presence in more than 40 countries. Its portfolio is made up of next generation ag products, mainly of biological synthesis, as well as adjuvants and special nutrition technologies. The company is part of the Bioceres Crop Solutions group, a global provider of solutions designed for sustainability in agriculture, listed on the NASDAQ.
Rizobacter has a 44-year history, where its parent company is located, and a 23-year history in the Brazilian market. The construction of the new plant, which will be built on a 65,000 m2 site in the municipality of Londrina, will require an investment of seven million dollars. The facilities will be used for the production of premium agricultural adjuvants and two laboratories for research and quality control of adjuvants and biological lines. An administration center will also operate there.
Rizobacter CEO Ricardo Yapur explained the basis for this important investment: “The demand for adjuvant solutions that improve the efficiency and quality of agricultural applications is growing rapidly in Brazil. We are talking about inputs inherent to the world’s largest crop protection market, which today is worth $12 billion. Our company has been working for more than 30 years in the development of adjuvant products with high added value, in strategic alliances with companies, to provide solutions that promote safe, efficient agricultural applications and are consistent with good agricultural practices. These are technologies that optimize chemical and biological control, the compatibility of recipes, and the operation of the spraying technique. If we think that 70 per cent of the performance of a phytosanitary is determined by the quality of its application, we can better measure the implications of these inputs,” he adds.
The expansion of operations in Brazil will generate 130 jobs, which will be added to the 85 collaborators that currently make up the firm’s workforce. “With the construction of this plant, which will be operational at the end of 2022, the company demonstrates its roots in the country and its intentions to provide a better service and grow in a market willing to invest in state-of-the-art technologies to achieve better performance with less impact on the environment,” said Nilton Elteto, general manager of Rizobacter Brasil.
A strength of the company’s global management is the multi-channel strategy to reach producers, and its ability to respond to the characteristics of each particular segment. Rizobacter’s portfolio is well focused on differentiated technologies, which add value to the agricultural business by improving production and environmental parameters. In Brazil, this investment will allow the development of specific solutions demanded locally which, accompanied by an excellent service provided by a professional team, are the pillars of the strategy for business growth.
Rizobacter, one of the leading global biological companies, announced the construction of the new plant in Brazil, adding significant depth to its international expansion. Currently, the company has eight subsidiaries in Latin America, the United States, Europe, and South Africa, and a commercial presence in more than 40 countries. Its portfolio is made up of next generation ag products, mainly of biological synthesis, as well as adjuvants and special nutrition technologies. The company is part of the Bioceres Crop Solutions group, a global provider of solutions designed for sustainability in agriculture, listed on the NASDAQ.
Rizobacter has a 44-year history in Argentina, where its parent company is located, and a 23-year history in the Brazilian market. The construction of the new plant, which will be built on a 65,000 m2 site in the municipality of Londrina, will require an investment of seven million dollars. The facilities will be used for the production of premium agricultural adjuvants and two laboratories for research and quality control of adjuvants and biological lines. An administration center will also operate there.
Rizobacter CEO Ricardo Yapur explained the basis for this important investment: “The demand for adjuvant solutions that improve the efficiency and quality of agricultural applications is growing rapidly in Brazil. We are talking about inputs inherent to the world’s largest crop protection market, which today is worth $12 billion. Our company has been working for more than 30 years in the development of adjuvant products with high added value, in strategic alliances with companies, to provide solutions that promote safe, efficient agricultural applications and are consistent with good agricultural practices. These are technologies that optimize chemical and biological control, the compatibility of recipes, and the operation of the spraying technique. If we think that 70 per cent of the performance of a phytosanitary is determined by the quality of its application, we can better measure the implications of these inputs,” he adds.
The expansion of operations in Brazil will generate 130 jobs, which will be added to the 85 collaborators that currently make up the firm’s workforce. “With the construction of this plant, which will be operational at the end of 2022, the company demonstrates its roots in the country and its intentions to provide a better service and grow in a market willing to invest in state-of-the-art technologies to achieve better performance with less impact on the environment,” said Nilton Elteto, general manager of Rizobacter Brasil.
A strength of the company’s global management is the multi-channel strategy to reach producers, and its ability to respond to the characteristics of each particular segment. Rizobacter’s portfolio is well focused on differentiated technologies, which add value to the agricultural business by improving production and environmental parameters. In Brazil, this investment will allow the development of specific solutions demanded locally which, accompanied by an excellent service provided by a professional team, are the pillars of the strategy for business growth.
Rizobacter construye nueva planta en Brasil y avanza en el mercado global de adyuvantes de uso agrícola
En 2022 prevé inaugurar en Londrina una planta de adyuvantes Premium para abastecer al creciente mercado de protección de cultivos
Rizobacter, una de las empresas líderes en biológicos a nivel global, anunció la construcción de una nueva planta en Brasil, profundizando así su expansión internacional. Actualmente, la compañía tiene ocho subsidiarias en Latam, Estados Unidos, Europa y Sudáfrica y presencia comercial en más de 40 países. Su portafolio está compuesto por productos de nueva generación, principalmente de síntesis biológica, así como por adyuvantes y tecnologías de nutrición especial. La empresa es parte del grupo Bioceres Crop Solutions, un proveedor global de soluciones diseñadas para la sostenibilidad en la agricultura, que cotiza en NASDAQ.
Rizobacter tiene una historia de 44 años en Argentina, donde se ubica su casa matriz, y una trayectoria de 23 años en el mercado brasilero. La construcción de la nueva planta, que se construirá sobre un terreno de 65.000 m2 en el municipio de Londrina, demandará una inversión de 7 millones de dólares. Las instalaciones se destinarán a la elaboración de adyuvantes agrícolas premium y a dos laboratorios para la investigación y control de calidad de las líneas de adyuvantes y biológicos. También funcionará allí un centro de administración.
El CEO de Rizobacter, Ricardo Yapur, explicó la base de esta importante inversión: “La demanda de soluciones adyuvantes que mejoren la eficiencia y la calidad de las aplicaciones agrícolas está creciendo rápidamente en Brasil. Estamos hablando de insumos inherentes al mercado de protección de cultivos más grande del mundo, que hoy tiene un valor de 12.000 millones de dólares. Nuestra empresa viene trabajando hace más de 30 años en el desarrollo de productos adyuvantes de alto valor agregado, en alianza estratégicas con empresas, para brindar soluciones que promuevan aplicaciones agrícolas seguras, eficientes y coherentes con las buenas prácticas agrícolas. Se trata de tecnologías que optimizan el control químico y biológico, la compatibilidad de las recetas y el funcionamiento de la técnica de pulverización. Si pensamos que el 70% de la performance de un fitosanitario está condicionada por la calidad de su aplicación, podemos dimensionar mejor las implicancias de estos insumos”, agrega.
La ampliación de las operaciones en Brasil generará 130 puestos de trabajo, que se sumarán a los 85 colaboradores que en la actualidad componen la plantilla de la firma. “Con la construcción de esta planta, que estará operativa a fines de 2022, la compañía demuestra su arraigo en el país y sus intenciones de dar un mejor servicio y crecer en un mercado dispuesto a invertir en tecnologías de última generación para lograr una mejor performance productiva con un menor impacto sobre el ambiente”, sostuvo Nilton Elteto, gerente general de Rizobacter Brasil.
Una fortaleza de la gestión global de la compañía es la estrategia multicanal para llegar a los productores, y su capacidad de responder a las características de cada segmento particular. El portafolio de Rizobacter está bien enfocado en tecnologías diferenciadas, que agregan valor al negocio agrícola mejorando parámetros productivos y ambientales. En Brasil, esta inversión permitirá desarrollar soluciones específicas demandadas localmente que, acompañadas de un servicio de excelencia brindado por un equipo profesional, son los pilares de la estrategia para el crecimiento del negocio.
Topics
Species
